U.S. Markets closed

Eiger BioPharma: 3Q Earnings Snapshot

PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $18.6 million in its third quarter.

The Palo Alto, California-based company said it had a loss of 76 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 77 cents per share.

Eiger BioPharma shares have risen slightly more than 6% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.80, a decline of 9% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR